Vaxelis Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

vaxelis

mcm vaccine b.v. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae types 2 and 3, hepatitis b surface antigen produced in yeast cells, poliovirus (inactivated): type 1 (mahoney), type 2 (mef-1), type 3 (saukett) produced in vero cells/ haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to meningococcal protein. - meningitis, haemophilus; poliomyelitis; tetanus; diphtheria; whooping cough; hepatitis b - vaccines - vaxelis (dtap-hb-ipv-hib) is indicated for primary and booster vaccination in infants and toddlers from the age of 6 weeks, against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and invasive diseases caused by haemophilus influenzae type b (hib). the use of vaxelis should be in accordance with official recommendations.

DIPHTHERIA AND TETANUS TOXOIDS ADSORBED LIQUID Kanada - Kiingereza - Health Canada

diphtheria and tetanus toxoids adsorbed liquid

aventis pasteur limited - diphtheria toxoid adsorbed; tetanus toxoid adsorbed - liquid - 25lf; 5lf - diphtheria toxoid adsorbed 25lf; tetanus toxoid adsorbed 5lf - toxoids

ADACEL pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5mL injection pre-filled needle-free syringe Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

adacel pertussis vaccine-acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5ml injection pre-filled needle-free syringe

sanofi-aventis australia pty ltd - diphtheria toxoid, quantity: 2 iu; pertussis filamentous haemagglutinin, quantity: 5 microgram; pertussis toxoid, quantity: 2.5 microgram; pertussis fimbriae 2 + 3, quantity: 5 microgram; pertactin, quantity: 3 microgram; tetanus toxoid, quantity: 20 iu - injection, suspension - excipient ingredients: glutaral; formaldehyde; phenoxyethanol; water for injections; aluminium phosphate - adacel is indicated for active immunisation against tetanus, diphtheria and pertussis in persons aged 10 years and over as a booster following primary immunisation. adacel may be administered during pregnancy for prevention of pertussis in young infants via transplacental antibody transfer from the pregnant woman to the fetus.

ADACEL-POLIO SUSPENSION Kanada - Kiingereza - Health Canada

adacel-polio suspension

sanofi pasteur limited - filamentous haemagglutinin; pertussis toxoid; pertactin; tetanus toxoid; fimbriae types 2 and 3 (fim); poliovirus type 1 mahoney (inactivated); poliovirus type 2 mef1 (inactivated); poliovirus type 3 saukett (inactivated); diphtheria toxoid - suspension - 5mcg; 2.5mcg; 3mcg; 5lf; 5mcg; 29unit; 7unit; 26unit; 2lf - filamentous haemagglutinin 5mcg; pertussis toxoid 2.5mcg; pertactin 3mcg; tetanus toxoid 5lf; fimbriae types 2 and 3 (fim) 5mcg; poliovirus type 1 mahoney (inactivated) 29unit; poliovirus type 2 mef1 (inactivated) 7unit; poliovirus type 3 saukett (inactivated) 26unit; diphtheria toxoid 2lf - vaccines

Pentavac Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and Haemophilus influenzae type b co Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

pentavac diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and haemophilus influenzae type b co

sanofi pasteur - purified diphtheria toxoid ph. eur.; purified tetanus toxoid; adsorbed purified pertussis toxoid; adsorbed purified filamentous haemagglutinin; inactivated poliomyelitis virus ph. eur; inactivated type 1 poliovirus; inactivated type 2 poliovirus; inactivated type 3 poliovirus; haemophilus influenzae type b, conjugate with tetanus protein - powder for suspension for injection - 0.5 millilitre(s) - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus

D T COQ Adsorbed vaccine Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

d t coq adsorbed vaccine

seqirus (nz) ltd - diphtheria toxoid, adsorbed 30 [iu] (not less than); pertussis vaccine, adsorbed 4 [iu] (minimum); tetanus toxoid, adsorbed 60 [iu] (not less than) - solution for injection - active: diphtheria toxoid, adsorbed 30 [iu] (not less than) pertussis vaccine, adsorbed 4 [iu] (minimum) tetanus toxoid, adsorbed 60 [iu] (not less than) excipient: aluminium hydroxide sodium chloride thiomersal water for injection

BOOSTRIX Israeli - Kiingereza - Ministry of Health

boostrix

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); pertactin (prn or 69 kda omp); pertussis toxoid (pt); tetanus toxoid - suspension for injection - diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid (pt) 8 mcg / 0.5 ml; pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml - tetanus toxoid, combinations with diphtheria toxoid - tetanus toxoid, combinations with diphtheria toxoid - for booster vaccination against diphtheria, tetanus and pertussis of individuals from the age of four years onwards.the administration of boostrix should be based on official recommendations

INFANRIX IPV HIB Israeli - Kiingereza - Ministry of Health

infanrix ipv hib

glaxo smith kline (israel) ltd - diphtheria toxoid; fillamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin; pertussis toxoid (pt); tetanus toxoid - powder and suspension for suspension for injection - diphtheria toxoid nlt 60 iu/ml; inactivated polio virus (ipv) type 3 64 du / 1 ml; inactivated polio virus (ipv) type 2 16 du / 1 ml; inactivated polio virus (ipv) type 1 80 du / 1 ml; pertussis toxoid (pt) 50 mcg/ml; fillamentous haemagglutinin (fha) 50 mcg/ml; pertactin 16 mcg/ml; tetanus toxoid nlt 80 iu/ml; haemophilus influenzae type b polysaccharide 20 mcg/vial - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - active immunisation in infants from the age of 2 months to 5 years against diptheria, tetanus, pertussis, poliomyelitis and haemophilus influenza type b. booster dose for children who have previously been immunised with dtp, polio and hib antigens

IPV Infanrix suspension for injection in pre-filled syringe Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed) Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

ipv infanrix suspension for injection in pre-filled syringe diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)

glaxosmithkline (ireland) limited - pertussis toxoid; filamentous haemagglutinin; pertactin; diphtheria toxoid; tetanus toxoid; polio virus type 1 inactivated; polio virus type 2 inactivated; polio virus type 3 inactivated - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - diphtheria-pertussis-poliomyelitis-tetanus

diTeBooster, suspension for injection in pre-filled single-dose syringes.Diphtheria and tetanus vaccine (adsorbed, reduced antigen content). Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

ditebooster, suspension for injection in pre-filled single-dose syringes.diphtheria and tetanus vaccine (adsorbed, reduced antigen content).

aj vaccines a/s - diphtheria toxoid; tetanus toxoid - suspension for injection in pre-filled syringe - . - tetanus vaccines; tetanus toxoid, combinations with diphtheria toxoid